KORU Medical Systems, Inc. KRMD
3.10 USD +0.05 (+1.64%)
At closeNov 3, 2026, 4:01 PM EST
3.10 0.00 0.00%
After hours · Nov 3, 4:01 PM ET
2.99 Day range 3.13
2.86 52-week range 6.61
- YTD
- -46.64%
- 1 year
- -19.27%
- Market cap
- 143.13M
- Revenue (ttm)
- 30.82M
- Profit margin
- -38.16%
- EPS (ttm)
- -0.04
- Shares out
- 45.84M
- Forward P/E
- -43.89
- YTD return
- -46.64%
- 1-year return
- -19.27%
- Volume
- 109.08K
- Avg volume
- 243.03K
- Open
- 3.05
- Previous close
- 3.05
- Day's range
- 2.99 – 3.13
- 52-week range
- 2.86 – 6.61
- Beta
- 0.41
- Analysts
- Strong Buy
- Price target
- 4.90 (+58.1%)
2Y +0.42 (+15.67%)
Key statistics
- Enterprise value
- 134.74M
- PEG ratio
- 0.00
- Price / sales
- 5.88
- Price / book
- 8.86
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 21.50%
- Free cash flow
- 1.05M
- Total cash
- 10.46M
- Total debt
- 3.97M
- Return on equity
- -50.25%
- Short % of float
- 2.06%
- 50-day average
- 3.27
- 200-day average
- 2.59
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 4.90 +58.1% upside
Now 3.10
- Target (low)
- 3.50
- Target (mean)
- 4.90
- Target (high)
- 7.00
Ratings (0m) 5 5 buy · 0 hold · 0 sell
- Strong buy1
- Buy4
- Hold0
- Sell0
- Strong sell0
Next earnings
Consensus EPS estimate -0.0325.
Financials — quick view
KRMD Revenue — quarterly 12.05M
KRMD Net income — quarterly 252.45K
KRMD EPS — quarterly 0.01
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 13, 2024 | Sep 1, 2024 | -0.03 | -0.03 | 0.00 | 0.00% |
| Aug 7, 2024 | Jun 1, 2024 | -0.04 | -0.02 | +0.02 | +50.00% |
| May 1, 2024 | Mar 1, 2024 | -0.04 | -0.02 | +0.02 | +50.00% |
| Mar 13, 2024 | Dec 1, 2023 | -0.04 | -0.02 | +0.02 | +50.00% |
| Nov 8, 2023 | Sep 1, 2023 | -0.04 | -0.03 | +0.01 | +25.00% |
| Aug 9, 2023 | Jun 1, 2023 | -0.05 | -0.05 | 0.00 | 0.00% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 14, 2024 | Craig-Hallum | main | Buy | Buy |
| Nov 14, 2024 | Canaccord Genuity | main | Buy | Buy |
| Nov 14, 2024 | Piper Sandler | main | Overweight | Overweight |
| Aug 8, 2024 | Piper Sandler | main | Overweight | Overweight |
| Mar 14, 2024 | B. Riley Securities | reit | Buy | Buy |
| Dec 7, 2023 | Canaccord Genuity | reit | Buy | Buy |
About KORU Medical Systems, Inc.
KORU Medical Systems, Inc. develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria. Its products include the FREEDOM60 syringe infusion system, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products. The company was incorporated in 1980 and is based in Mahwah, New Jersey.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Country
- United States
- Website
- korumedical.com
News
KORU Medical Systems to Report Third Quarter 2026 Financial Results on November 10, 2026 
Reviewing Organigram Global (NASDAQ:OGI) & KORU Medical Systems (NASDAQ:KRMD) 
KORU Medical Systems, Inc. (KRMD) Q2 2026 Earnings Call Transcript 
KORU Medical Systems Q2 Earnings Call Highlights 
KORU Medical Systems, Inc. (KRMD) Q2 Earnings and Revenues Beat Estimates 
Koru Medical Systems Withdraws 510(K) Application For FreedomEDGE With Phesgo In U.S. To Focus On Alternative Higher Volume Molecules 
KORU Medical Systems Narrows FY2026 Sales Guidance from $47.500M-$50.000M to $47.500M-$48.500M vs $48.688M Est 
KORU Medical Systems Q2 Adj. EPS $0.02 Beats $(0.02) Estimate, Sales $12.045M Beat $11.609M Estimate 
KORU Medical Systems Announces Second Quarter 2026 Results and Updates Full Year 2026 Guidance 
KORU Medical Systems to Participate in the Canaccord Genuity 46th Annual Growth Conference
Your note
Sign in to keep a note on KRMD — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BECK JAMES M. | Director | Stock Award(Grant) | Jun 29, 2023 | 90,284 |
| CASCELLA ROBERT A | Director | Stock Award(Grant) | Sep 30, 2024 | 70,978 |
| FLETCHER R JOHN | Chairman of the Board | Stock Award(Grant) | Sep 30, 2024 | 190,851 |
| FRENCH DONNA | Director | Stock Award(Grant) | Sep 30, 2024 | 70,978 |
| MANKO JOSEPH M JR | Director and Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) | Sep 29, 2024 | 0 |
| MATIN SHAHRIAR | Director | Stock Award(Grant) | Sep 30, 2024 | 73,608 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| First Light Asset Management, LLC | 14.04% | 5,598,925 | 22.12M | Sep 29, 2024 |
| Vanguard Group Inc | 4.47% | 1,782,801 | 7.04M | Sep 29, 2024 |
| Meros Investment Management, Lp | 2.02% | 805,384 | 3.18M | Sep 29, 2024 |
| Albion Financial Group | 1.67% | 667,783 | 2.64M | Sep 29, 2024 |
| RBF Capital, LLC | 1.31% | 521,319 | 2.06M | Sep 29, 2024 |
| Geode Capital Management, LLC | 1.16% | 462,128 | 1.83M | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 2.86% | 1,140,651 | 4.51M | Sep 29, 2024 |
| Vanguard Extended Market Index Fund | 1.45% | 579,541 | 2.29M | Sep 29, 2024 |
| Fidelity Extended Market Index Fund | 0.62% | 245,888 | 971.26K | Oct 30, 2024 |
| iShares Micro Cap ETF | 0.21% | 85,301 | 336.94K | Oct 30, 2024 |
| Fidelity Total Market Index Fund | 0.18% | 73,136 | 288.89K | Oct 30, 2024 |
| Forum Funds II-Acuitas U.S. Micro Cap Fund | 0.17% | 68,232 | 269.52K | Sep 29, 2024 |